Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...

Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...

Pregnancy and childbirth are usually filled with anticipation and hope. Modern obstetrics has dramatically improved the ...

BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...

Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

Remote ischaemic conditioning preserved cardiac function during anthracycline therapy without reducing tumour suppression.

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...